Angel investing is not a side activity. It is a strategic extension of our conviction that Africa's most durable solutions will be built by bold founders who have access to the right capital, networks, and guidance at exactly the right time.
Start a Conversation →We take a thesis-driven approach to early-stage investing. Our priority sectors reflect both market opportunity and personal conviction built across two decades at the intersection of medicine, public health, and business leadership.
We invest through Tekedia Capital and other vehicles, always as active partners. A cheque without mentorship is an incomplete investment.
Africa faces a structural deficit in healthcare access. Technology that closes gaps in diagnostics, telemedicine, and care delivery is urgent capital, not optional investment.
Transforming healthcare requires transforming the leaders within it. Platforms that build clinical and executive capability at scale deserve backing and deserve it early.
Payment rails, logistics networks, and SaaS tools that reduce the friction of building in Africa accelerate everything built on top of them. These are foundational bets.
Businesses that generate commercial returns while expanding opportunity, particularly in underserved communities across Sub-Saharan Africa. Returns and impact are not opposites.
Money is the smallest part of what we offer. We invest as active partners who are deeply invested in the outcome.
Before we deploy capital, we want to understand the founder as much as the product. These are the three questions that determine whether we proceed.
Do they understand the root cause of the problem they are solving, or are they treating symptoms? Founders who think in root causes build more durable companies.
Africa's infrastructure for digital business is evolving rapidly. Is this venture positioned for where the market is going, not just where it is today?
Growth that harms communities or undermines trust is not growth worth funding. We back ventures that earn their market, not exploit it.
We are not transactional investors. Before we deploy capital, we want to understand the founder as much as the product.
If you are building in health, education, or startup infrastructure in Sub-Saharan Africa and are at the early stage, we would like to hear from you. Initial conversations are always confidential. Pitch decks are reviewed on a rolling basis.